Article citationsMore>>

Liu, L.Y., Craiglow, B.G., Dai, F. and King, B.A. (2017) Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients. Journal of the Ameri-can Academy of Dermatology, 76, 22-28.

has been cited by the following article:

• TITLE: Understanding Alopecia Areata: Types, Causes, and Latest Therapeutic Approaches

  AUTHORS: Noorah Saleh Al-Sowayan, Asal Khalid AlRebdi, Maryah Khalaf AlMarwani

  KEYWORDS: Genetics, Microorganisms, Stress, Psychological Pressure, Covid 19

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.11, November 18, 2024

  ABSTRACT: Background: Alopecia areata (AA) is a common autoimmune condition that causes hair loss. Affecting 0.5% - 2% of the population, AA manifests in several types, from mild to severe. Objectives: This study aimed to examine AA’s etiology and innovative treatments of AA, presenting a comprehensive overview of existing and investigational therapies. Methods: We conducted a systematic literature review and screened recent studies to gain insight into treatment efficacy and outcomes. Results: The complexity of AA and the potential for novel therapies enhanced patients’ quality of life. Conclusions: There is a need for further research into AA’s genetic underpinnings of AA and more targeted treatments.